| pubmed-article:14501648 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14501648 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:14501648 | lifeskim:mentions | umls-concept:C1456649 | lld:lifeskim |
| pubmed-article:14501648 | lifeskim:mentions | umls-concept:C0042034 | lld:lifeskim |
| pubmed-article:14501648 | lifeskim:mentions | umls-concept:C0080274 | lld:lifeskim |
| pubmed-article:14501648 | lifeskim:mentions | umls-concept:C0001641 | lld:lifeskim |
| pubmed-article:14501648 | pubmed:issue | 4 Pt 2 | lld:pubmed |
| pubmed-article:14501648 | pubmed:dateCreated | 2003-9-22 | lld:pubmed |
| pubmed-article:14501648 | pubmed:abstractText | Alpha blocker therapy has been successfully used to decrease residual urine in children with complex neuropathic and nonneuropathic voiding dysfunction. We evaluated the safety and efficacy of using selective alpha blocker therapy for children with uncomplicated voiding dysfunction and underlying poor bladder emptying. | lld:pubmed |
| pubmed-article:14501648 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14501648 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14501648 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:14501648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14501648 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14501648 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14501648 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:14501648 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:14501648 | pubmed:author | pubmed-author:HerndonC D... | lld:pubmed |
| pubmed-article:14501648 | pubmed:author | pubmed-author:AustinPaul... | lld:pubmed |
| pubmed-article:14501648 | pubmed:author | pubmed-author:CainMark PMP | lld:pubmed |
| pubmed-article:14501648 | pubmed:author | pubmed-author:RinkRichard... | lld:pubmed |
| pubmed-article:14501648 | pubmed:author | pubmed-author:WuSimon DSD | lld:pubmed |
| pubmed-article:14501648 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14501648 | pubmed:volume | 170 | lld:pubmed |
| pubmed-article:14501648 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14501648 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14501648 | pubmed:pagination | 1514-5; discussion 1516-7 | lld:pubmed |
| pubmed-article:14501648 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:meshHeading | pubmed-meshheading:14501648... | lld:pubmed |
| pubmed-article:14501648 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14501648 | pubmed:articleTitle | Alpha blocker therapy for children with dysfunctional voiding and urinary retention. | lld:pubmed |
| pubmed-article:14501648 | pubmed:affiliation | Department of Urology, Indiana University School of Medicine, Indianapolis, USA. mpcain@iupui.edu | lld:pubmed |
| pubmed-article:14501648 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14501648 | pubmed:publicationType | Clinical Trial | lld:pubmed |
